Who is sponsoring NCT06270173?

NCT06270173 is sponsored by Wiltrom Co., Ltd..

What drugs are being tested in NCT06270173?

Interventions in NCT06270173: Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix).

What condition does NCT06270173 study?

NCT06270173 studies Osteoporotic Vertebral Compression Fractures.

Is NCT06270173 still recruiting?

NCT06270173 is currently active, enrolled. Last updated 22 January 2025.

Last reviewed 2025-01-22 · How we verify

NCT06270173

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures

Active, enrolled NA Last updated 22 January 2025

What this trial tests

NA trial testing Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix) in Osteoporotic Vertebral Compression Fractures in 53 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

16 February 2024

Primary endpoint
31 December 2025

28 February 2026

Quick facts

Lead sponsor	Wiltrom Co., Ltd.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	53
Start date	16 February 2024
Primary completion	31 December 2025
Estimated completion	28 February 2026
Sites	4 locations across Germany

Drugs / interventions tested

Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix)

Conditions studied

Osteoporotic Vertebral Compression Fractures — all drugs for Osteoporotic Vertebral Compression Fractures →

Sponsor

Wiltrom Co., Ltd.

Who can join

18 and older, any sex, with Osteoporotic Vertebral Compression Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this Post-Market Clinical Follow-Up Study is to evaluate the safety and performance of the Tripod-Fix in the treatment of vertebral compression fractures (VCF) resulting from osteoporosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix)

Trials testing the same drug.

NCT06261242 — Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures Treatment · NA · active not recruiting

Other recruiting trials for Osteoporotic Vertebral Compression Fractures

Currently open trials in the same condition.

NCT06261242 — Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures Treatment · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06270173 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wiltrom Co., Ltd.
Last refreshed: 22 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing